Abiopharma

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in Interest of Director

Innovex Enters Into Agreement to Acquire TCO Group

BRC Group Holdings, Inc. Provides Update on SpaceX Carried Interest Position

Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2026 EHA Congress in Oral Presentation

Jack in the Box Inc. Prices $500 Million Securitized Financing Facility

Plains All American Pipeline and Plains GP Holdings Provide Updated Capital Spending Guidance for 2026

Safehold Declares Second Quarter 2026 Common Stock Dividend

Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome

Immuneering Appoints Andrew Gengos as Chief Financial Officer

Aramark Student Nutrition Announces Nationwide Update to School Menus for 2026–2027